Regeneron starts late-stage trials of antiviral antibody cocktail in Covid-19
Source: https://ift.tt/3iCY7Xq
The studies of the two-antibody cocktail REGN-COV2 include a Phase III trial to prevent infection among people who have been exposed to infected patients and two Phase II/III trials, in hospitalized and non-hospitalized patients with the disease.
Source: https://ift.tt/3iCY7Xq
0 Comments